nerd
Senior Member
- Messages
- 863
In face of the current Ivermectin discussion, I'd like to reopen an old post in the context of chronic parasite infection.
Firstly, I'd like to cover the nematode Strongyloides Stercoralis. Here is one recent study that shows the prevalence in rural Cambodia and its chronified symptoms (10.1371/journal.pntd.0005685). It involves abdominal pain, nausea, vomiting, diarrhea, urticaria, and cough. Since the chronic type of this parasite infection usually remains unnoticed, it can develop from a chronic to an opportunistic and severe co-infection.
So it's not surprising to find various reports of hyperinfection in COVID-19 patients once given immune suppression.
Considering how prevalent these parasites might be, even in developed countries, I wonder how often this is really tested. Not only tested in COVID-19 patients but also "long haulers", patients with other chronic/recurring viral infections, with unspecific chronified symptoms, and with CFS/ME. The only chronic viral infection that has been cross-evaluated with S. Stercoralis is HIV (10.1371/journal.pntd.0001581). Except for this single case report of a triple infection of herpes, with a fungus and the parasite (10.1016/j.rmcr.2020.101330).
Do you know of any guidelines in which either of these parasites have been included as differential or co-diagnosis?
Does anyone know of case reports of people with chronic infections and/or chronic fatigue who were checked for these parasites (either negative or positive)?
Why do you think have these parasites never received a lot of research attention in the pre-COVID-19 era and even now?
Firstly, I'd like to cover the nematode Strongyloides Stercoralis. Here is one recent study that shows the prevalence in rural Cambodia and its chronified symptoms (10.1371/journal.pntd.0005685). It involves abdominal pain, nausea, vomiting, diarrhea, urticaria, and cough. Since the chronic type of this parasite infection usually remains unnoticed, it can develop from a chronic to an opportunistic and severe co-infection.
So it's not surprising to find various reports of hyperinfection in COVID-19 patients once given immune suppression.
- Case Report: Disseminated Strongyloidiasis in a Patient with COVID-19 (10.4269/ajtmh.20-0699)
- Strongyloides infection manifested during immunosuppressive therapy for SARS-CoV-2 pneumonia (10.1007/s15010-020-01522-4)
- COVID-19 and Strongyloides (10.2139/ssrn.3766955)
- Risk of Strongyloides Hyperinfection Syndrome when prescribing dexamethasone in severe COVID-19 (10.1016/j.tmaid.2021.101981)
- COVID-19 and Dexamethasone - A Potential Strategy to Avoid Steroid-Related Strongyloides Hyperinfection (10.1001/jama.2020.13170)
- A parasitic infection that can turn fatal with administration of corticosteroids (WHO)
Considering how prevalent these parasites might be, even in developed countries, I wonder how often this is really tested. Not only tested in COVID-19 patients but also "long haulers", patients with other chronic/recurring viral infections, with unspecific chronified symptoms, and with CFS/ME. The only chronic viral infection that has been cross-evaluated with S. Stercoralis is HIV (10.1371/journal.pntd.0001581). Except for this single case report of a triple infection of herpes, with a fungus and the parasite (10.1016/j.rmcr.2020.101330).
Do you know of any guidelines in which either of these parasites have been included as differential or co-diagnosis?
Does anyone know of case reports of people with chronic infections and/or chronic fatigue who were checked for these parasites (either negative or positive)?
Why do you think have these parasites never received a lot of research attention in the pre-COVID-19 era and even now?
Last edited: